Amphotericin B and Curcumin Co-Loaded Porous Microparticles as a Sustained Release System against <i>Candida albicans</i>
Amphotericin B (AMB) is an antifungal drug used for serious fungal infections. However, AMB has adverse reactions such as nephrotoxicity, which limit the clinical application of AMB alone or in combination with other antifungal drugs. Nano or micro drug delivery systems (DDS) have been proven to be...
Main Authors: | Baiji Xue, Yanhua Yu, Guoqiang Peng, Mengmeng Sun, Peng Lv, Xuefeng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/10/3079 |
Similar Items
-
Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
by: Lucas Soares Bezerra, et al.
Published: (2020-05-01) -
Efficacy of oral amphotericin B for refractory atopic dermatitis with specific IgE to Candida albicans and food allergens in sera
by: Kazuko Kitamura, et al.
Published: (1997-01-01) -
Recent developments on the anti-Candida effect of amphotericin B combined with a second drug - a mini-review
by: DANIEL C. DE MORAES
Published: (2023-05-01) -
Nicotinamide potentiates amphotericin B activity against Candida albicans
by: Yu Yan, et al.
Published: (2022-12-01) -
Growth and Antifungal Resistance of the Pathogenic Yeast, <i>Candida Albicans</i>, in the Microgravity Environment of the International Space Station: An Aggregate of Multiple Flight Experiences
by: Sheila Nielsen, et al.
Published: (2021-03-01)